Clinical Study of Later Course Accelerated Hyperfractionation Radiotherapy Adjuvant with Cisplatin in Treatment of Esophageal Carcinoma

Objective To evaluate the value of later course accelerated hyperfractionation radiotherapy (LCAHR) adjuvant with cisplatin in treatment of esophageal carcinoma and the effect on the immune state of the patients. Methods 104 cases of squamous cell carcinoma of esophagus were randomized into group A (53 patients) and group B (51 patients). Group A received a dose of 30Gy with conventional fractionation in first 3 weeks and 30Gy with 1.5Gy/f, twice per day in later 2 weeks. A total dose is 60Gy/35f/5 weeks....